nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—CYP1B1—Dexamethasone—psoriatic arthritis	0.0629	0.189	CbGbCtD
Dasatinib—SRMS—knee—psoriatic arthritis	0.0337	0.256	CbGeAlD
Dasatinib—ABCG2—Dexamethasone—psoriatic arthritis	0.0299	0.0901	CbGbCtD
Dasatinib—ABCB1—Methylprednisolone—psoriatic arthritis	0.0285	0.0859	CbGbCtD
Dasatinib—CYP1A1—Dexamethasone—psoriatic arthritis	0.0276	0.0832	CbGbCtD
Dasatinib—ABCG2—Methotrexate—psoriatic arthritis	0.024	0.0724	CbGbCtD
Dasatinib—ABCB1—Betamethasone—psoriatic arthritis	0.0185	0.0558	CbGbCtD
Dasatinib—ABCB1—Prednisolone—psoriatic arthritis	0.0183	0.0551	CbGbCtD
Dasatinib—ABCB1—Prednisone—psoriatic arthritis	0.0173	0.052	CbGbCtD
Dasatinib—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0171	0.0515	CbGbCtD
Dasatinib—CYP3A5—Dexamethasone—psoriatic arthritis	0.0166	0.0499	CbGbCtD
Dasatinib—CYP3A4—Triamcinolone—psoriatic arthritis	0.013	0.039	CbGbCtD
Dasatinib—CYP3A4—Betamethasone—psoriatic arthritis	0.0111	0.0335	CbGbCtD
Dasatinib—CYP3A4—Prednisolone—psoriatic arthritis	0.011	0.033	CbGbCtD
Dasatinib—ABCB1—Dexamethasone—psoriatic arthritis	0.0108	0.0325	CbGbCtD
Dasatinib—RIPK2—synovial membrane of synovial joint—psoriatic arthritis	0.0107	0.0811	CbGeAlD
Dasatinib—CYP3A4—Prednisone—psoriatic arthritis	0.0104	0.0312	CbGbCtD
Dasatinib—ABCB1—Methotrexate—psoriatic arthritis	0.00867	0.0261	CbGbCtD
Dasatinib—CYP3A4—Dexamethasone—psoriatic arthritis	0.00646	0.0195	CbGbCtD
Dasatinib—TEC—tendon—psoriatic arthritis	0.00441	0.0334	CbGeAlD
Dasatinib—BMX—skin of body—psoriatic arthritis	0.00382	0.029	CbGeAlD
Dasatinib—PTK6—skin of body—psoriatic arthritis	0.00358	0.0271	CbGeAlD
Dasatinib—EPHB1—tendon—psoriatic arthritis	0.00346	0.0262	CbGeAlD
Dasatinib—STAT5B—skin of body—psoriatic arthritis	0.00339	0.0257	CbGeAlD
Dasatinib—SIK3—tendon—psoriatic arthritis	0.00232	0.0176	CbGeAlD
Dasatinib—STK35—skin of body—psoriatic arthritis	0.00231	0.0175	CbGeAlD
Dasatinib—CSK—skin of body—psoriatic arthritis	0.00229	0.0174	CbGeAlD
Dasatinib—ZAK—tendon—psoriatic arthritis	0.00215	0.0163	CbGeAlD
Dasatinib—RIPK2—skin of body—psoriatic arthritis	0.00213	0.0161	CbGeAlD
Dasatinib—SIK1—skin of body—psoriatic arthritis	0.00208	0.0157	CbGeAlD
Dasatinib—BTK—tendon—psoriatic arthritis	0.00206	0.0156	CbGeAlD
Dasatinib—ERBB3—skin of body—psoriatic arthritis	0.00204	0.0154	CbGeAlD
Dasatinib—TESK1—tendon—psoriatic arthritis	0.0019	0.0144	CbGeAlD
Dasatinib—MAPK14—skin of body—psoriatic arthritis	0.0019	0.0144	CbGeAlD
Dasatinib—STK36—tendon—psoriatic arthritis	0.00187	0.0142	CbGeAlD
Dasatinib—JAK2—skin of body—psoriatic arthritis	0.00178	0.0135	CbGeAlD
Dasatinib—FYN—skin of body—psoriatic arthritis	0.00176	0.0133	CbGeAlD
Dasatinib—STK35—tendon—psoriatic arthritis	0.00176	0.0133	CbGeAlD
Dasatinib—CSK—tendon—psoriatic arthritis	0.00174	0.0132	CbGeAlD
Dasatinib—HCK—tendon—psoriatic arthritis	0.00172	0.0131	CbGeAlD
Dasatinib—MAP3K3—skin of body—psoriatic arthritis	0.00172	0.013	CbGeAlD
Dasatinib—ABL2—tendon—psoriatic arthritis	0.00171	0.013	CbGeAlD
Dasatinib—EPHB6—skin of body—psoriatic arthritis	0.00164	0.0125	CbGeAlD
Dasatinib—RIPK2—tendon—psoriatic arthritis	0.00162	0.0123	CbGeAlD
Dasatinib—SIK1—tendon—psoriatic arthritis	0.00158	0.012	CbGeAlD
Dasatinib—EPHA4—tendon—psoriatic arthritis	0.00157	0.0119	CbGeAlD
Dasatinib—SRC—skin of body—psoriatic arthritis	0.00153	0.0116	CbGeAlD
Dasatinib—MAPK14—tendon—psoriatic arthritis	0.00144	0.0109	CbGeAlD
Dasatinib—FGR—tendon—psoriatic arthritis	0.00144	0.0109	CbGeAlD
Dasatinib—CSF1R—skin of body—psoriatic arthritis	0.00137	0.0104	CbGeAlD
Dasatinib—EPHB4—tendon—psoriatic arthritis	0.00137	0.0104	CbGeAlD
Dasatinib—JAK2—tendon—psoriatic arthritis	0.00136	0.0103	CbGeAlD
Dasatinib—EPHA2—tendon—psoriatic arthritis	0.00134	0.0102	CbGeAlD
Dasatinib—FYN—tendon—psoriatic arthritis	0.00134	0.0102	CbGeAlD
Dasatinib—MAP3K3—tendon—psoriatic arthritis	0.00131	0.00993	CbGeAlD
Dasatinib—MAP4K5—tendon—psoriatic arthritis	0.00131	0.00993	CbGeAlD
Dasatinib—EPHB6—tendon—psoriatic arthritis	0.00125	0.00949	CbGeAlD
Dasatinib—KIT—skin of body—psoriatic arthritis	0.00125	0.00945	CbGeAlD
Dasatinib—PDGFRB—skin of body—psoriatic arthritis	0.00122	0.00923	CbGeAlD
Dasatinib—YES1—tendon—psoriatic arthritis	0.00121	0.00917	CbGeAlD
Dasatinib—PDGFRA—tendon—psoriatic arthritis	0.00119	0.00899	CbGeAlD
Dasatinib—ABL1—skin of body—psoriatic arthritis	0.00108	0.00822	CbGeAlD
Dasatinib—MAP2K5—tendon—psoriatic arthritis	0.00107	0.00811	CbGeAlD
Dasatinib—CSF1R—tendon—psoriatic arthritis	0.00104	0.00792	CbGeAlD
Dasatinib—PDGFRB—tendon—psoriatic arthritis	0.000926	0.00702	CbGeAlD
Dasatinib—CYP1B1—skin of body—psoriatic arthritis	0.000919	0.00696	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Methylprednisolone—psoriatic arthritis	0.00084	0.0989	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Betamethasone—psoriatic arthritis	0.000827	0.0973	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Dexamethasone—psoriatic arthritis	0.000827	0.0973	CbGdCrCtD
Dasatinib—ABL1—tendon—psoriatic arthritis	0.000826	0.00626	CbGeAlD
Dasatinib—EPHB2—Diflorasone—Triamcinolone—psoriatic arthritis	0.000808	0.0951	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Prednisone—psoriatic arthritis	0.000767	0.0902	CbGdCrCtD
Dasatinib—EPHB2—Diflorasone—Prednisolone—psoriatic arthritis	0.000749	0.0881	CbGdCrCtD
Dasatinib—CYP1B1—tendon—psoriatic arthritis	0.000699	0.0053	CbGeAlD
Dasatinib—CYP1A1—skin of body—psoriatic arthritis	0.000649	0.00492	CbGeAlD
Dasatinib—PKMYT1—Danazol—Prednisone—psoriatic arthritis	0.000435	0.0512	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000342	0.0402	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000342	0.0402	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Dexamethasone—psoriatic arthritis	0.000336	0.0396	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Betamethasone—psoriatic arthritis	0.000336	0.0396	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Triamcinolone—psoriatic arthritis	0.000328	0.0386	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Triamcinolone—psoriatic arthritis	0.000328	0.0386	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisone—psoriatic arthritis	0.000312	0.0367	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisone—psoriatic arthritis	0.000312	0.0367	CbGdCrCtD
Dasatinib—TESK1—Dexamethasone—Prednisolone—psoriatic arthritis	0.000304	0.0358	CbGdCrCtD
Dasatinib—TESK1—Betamethasone—Prednisolone—psoriatic arthritis	0.000304	0.0358	CbGdCrCtD
Dasatinib—Malaise—Betamethasone—psoriatic arthritis	0.000257	0.000891	CcSEcCtD
Dasatinib—Malaise—Dexamethasone—psoriatic arthritis	0.000257	0.000891	CcSEcCtD
Dasatinib—Oedema—Triamcinolone—psoriatic arthritis	0.000256	0.000888	CcSEcCtD
Dasatinib—Vertigo—Betamethasone—psoriatic arthritis	0.000256	0.000887	CcSEcCtD
Dasatinib—Vertigo—Dexamethasone—psoriatic arthritis	0.000256	0.000887	CcSEcCtD
Dasatinib—Syncope—Betamethasone—psoriatic arthritis	0.000256	0.000886	CcSEcCtD
Dasatinib—Syncope—Dexamethasone—psoriatic arthritis	0.000256	0.000886	CcSEcCtD
Dasatinib—Arrhythmia—Prednisone—psoriatic arthritis	0.000255	0.000883	CcSEcCtD
Dasatinib—Infection—Triamcinolone—psoriatic arthritis	0.000255	0.000883	CcSEcCtD
Dasatinib—Infection—Methylprednisolone—psoriatic arthritis	0.000254	0.000881	CcSEcCtD
Dasatinib—Haematuria—Methotrexate—psoriatic arthritis	0.000253	0.000877	CcSEcCtD
Dasatinib—Shock—Triamcinolone—psoriatic arthritis	0.000252	0.000874	CcSEcCtD
Dasatinib—Insomnia—Prednisolone—psoriatic arthritis	0.000252	0.000874	CcSEcCtD
Dasatinib—Alopecia—Prednisone—psoriatic arthritis	0.000252	0.000873	CcSEcCtD
Dasatinib—Shock—Methylprednisolone—psoriatic arthritis	0.000252	0.000872	CcSEcCtD
Dasatinib—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000251	0.00087	CcSEcCtD
Dasatinib—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000251	0.000869	CcSEcCtD
Dasatinib—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000251	0.000868	CcSEcCtD
Dasatinib—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000251	0.000868	CcSEcCtD
Dasatinib—Epistaxis—Methotrexate—psoriatic arthritis	0.00025	0.000868	CcSEcCtD
Dasatinib—Tachycardia—Triamcinolone—psoriatic arthritis	0.00025	0.000867	CcSEcCtD
Dasatinib—Mental disorder—Prednisone—psoriatic arthritis	0.00025	0.000866	CcSEcCtD
Dasatinib—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00025	0.000865	CcSEcCtD
Dasatinib—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000248	0.000861	CcSEcCtD
Dasatinib—Erythema—Prednisone—psoriatic arthritis	0.000248	0.00086	CcSEcCtD
Dasatinib—Malnutrition—Prednisone—psoriatic arthritis	0.000248	0.00086	CcSEcCtD
Dasatinib—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000248	0.000859	CcSEcCtD
Dasatinib—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000247	0.000857	CcSEcCtD
Dasatinib—Convulsion—Dexamethasone—psoriatic arthritis	0.000247	0.000856	CcSEcCtD
Dasatinib—Convulsion—Betamethasone—psoriatic arthritis	0.000247	0.000856	CcSEcCtD
Dasatinib—Hypertension—Dexamethasone—psoriatic arthritis	0.000246	0.000853	CcSEcCtD
Dasatinib—Hypertension—Betamethasone—psoriatic arthritis	0.000246	0.000853	CcSEcCtD
Dasatinib—Myalgia—Dexamethasone—psoriatic arthritis	0.000243	0.000841	CcSEcCtD
Dasatinib—Myalgia—Betamethasone—psoriatic arthritis	0.000243	0.000841	CcSEcCtD
Dasatinib—Anxiety—Betamethasone—psoriatic arthritis	0.000242	0.000838	CcSEcCtD
Dasatinib—Anxiety—Dexamethasone—psoriatic arthritis	0.000242	0.000838	CcSEcCtD
Dasatinib—Discomfort—Dexamethasone—psoriatic arthritis	0.00024	0.000831	CcSEcCtD
Dasatinib—Discomfort—Betamethasone—psoriatic arthritis	0.00024	0.000831	CcSEcCtD
Dasatinib—Haemoglobin—Methotrexate—psoriatic arthritis	0.00024	0.00083	CcSEcCtD
Dasatinib—Hypotension—Methylprednisolone—psoriatic arthritis	0.000239	0.000828	CcSEcCtD
Dasatinib—Pain—Prednisolone—psoriatic arthritis	0.000238	0.000826	CcSEcCtD
Dasatinib—Hepatitis—Methotrexate—psoriatic arthritis	0.000238	0.000826	CcSEcCtD
Dasatinib—Haemorrhage—Methotrexate—psoriatic arthritis	0.000238	0.000826	CcSEcCtD
Dasatinib—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000235	0.000816	CcSEcCtD
Dasatinib—Vision blurred—Prednisone—psoriatic arthritis	0.000234	0.000811	CcSEcCtD
Dasatinib—Urethral disorder—Methotrexate—psoriatic arthritis	0.000234	0.000809	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000234	0.000809	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000233	0.000808	CcSEcCtD
Dasatinib—Oedema—Dexamethasone—psoriatic arthritis	0.000233	0.000806	CcSEcCtD
Dasatinib—Oedema—Betamethasone—psoriatic arthritis	0.000233	0.000806	CcSEcCtD
Dasatinib—Insomnia—Triamcinolone—psoriatic arthritis	0.000232	0.000804	CcSEcCtD
Dasatinib—Insomnia—Methylprednisolone—psoriatic arthritis	0.000231	0.000802	CcSEcCtD
Dasatinib—Infection—Dexamethasone—psoriatic arthritis	0.000231	0.000801	CcSEcCtD
Dasatinib—Infection—Betamethasone—psoriatic arthritis	0.000231	0.000801	CcSEcCtD
Dasatinib—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00023	0.000798	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00023	0.000796	CcSEcCtD
Dasatinib—Visual impairment—Methotrexate—psoriatic arthritis	0.00023	0.000796	CcSEcCtD
Dasatinib—Anaemia—Prednisone—psoriatic arthritis	0.000229	0.000795	CcSEcCtD
Dasatinib—Shock—Dexamethasone—psoriatic arthritis	0.000229	0.000793	CcSEcCtD
Dasatinib—Shock—Betamethasone—psoriatic arthritis	0.000229	0.000793	CcSEcCtD
Dasatinib—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000229	0.000792	CcSEcCtD
Dasatinib—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000228	0.000791	CcSEcCtD
Dasatinib—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000228	0.000791	CcSEcCtD
Dasatinib—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000228	0.000789	CcSEcCtD
Dasatinib—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000228	0.000789	CcSEcCtD
Dasatinib—Tachycardia—Betamethasone—psoriatic arthritis	0.000227	0.000787	CcSEcCtD
Dasatinib—Tachycardia—Dexamethasone—psoriatic arthritis	0.000227	0.000787	CcSEcCtD
Dasatinib—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000226	0.000782	CcSEcCtD
Dasatinib—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000225	0.000781	CcSEcCtD
Dasatinib—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000225	0.00078	CcSEcCtD
Dasatinib—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000225	0.000779	CcSEcCtD
Dasatinib—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000225	0.000779	CcSEcCtD
Dasatinib—Malaise—Prednisone—psoriatic arthritis	0.000224	0.000776	CcSEcCtD
Dasatinib—Vertigo—Prednisone—psoriatic arthritis	0.000223	0.000773	CcSEcCtD
Dasatinib—Eye disorder—Methotrexate—psoriatic arthritis	0.000223	0.000772	CcSEcCtD
Dasatinib—Syncope—Prednisone—psoriatic arthritis	0.000223	0.000771	CcSEcCtD
Dasatinib—Tinnitus—Methotrexate—psoriatic arthritis	0.000222	0.00077	CcSEcCtD
Dasatinib—Anorexia—Betamethasone—psoriatic arthritis	0.000222	0.000768	CcSEcCtD
Dasatinib—Anorexia—Dexamethasone—psoriatic arthritis	0.000222	0.000768	CcSEcCtD
Dasatinib—Urticaria—Prednisolone—psoriatic arthritis	0.000221	0.000767	CcSEcCtD
Dasatinib—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000221	0.000766	CcSEcCtD
Dasatinib—Fatigue—Triamcinolone—psoriatic arthritis	0.000221	0.000766	CcSEcCtD
Dasatinib—Fatigue—Methylprednisolone—psoriatic arthritis	0.000221	0.000764	CcSEcCtD
Dasatinib—Pain—Triamcinolone—psoriatic arthritis	0.000219	0.00076	CcSEcCtD
Dasatinib—Loss of consciousness—Prednisone—psoriatic arthritis	0.000218	0.000756	CcSEcCtD
Dasatinib—Hypotension—Betamethasone—psoriatic arthritis	0.000217	0.000753	CcSEcCtD
Dasatinib—Hypotension—Dexamethasone—psoriatic arthritis	0.000217	0.000753	CcSEcCtD
Dasatinib—Angiopathy—Methotrexate—psoriatic arthritis	0.000216	0.000749	CcSEcCtD
Dasatinib—Immune system disorder—Methotrexate—psoriatic arthritis	0.000215	0.000746	CcSEcCtD
Dasatinib—Convulsion—Prednisone—psoriatic arthritis	0.000215	0.000745	CcSEcCtD
Dasatinib—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000215	0.000744	CcSEcCtD
Dasatinib—Hypertension—Prednisone—psoriatic arthritis	0.000214	0.000743	CcSEcCtD
Dasatinib—Chills—Methotrexate—psoriatic arthritis	0.000214	0.000741	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000212	0.000734	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000212	0.000734	CcSEcCtD
Dasatinib—Myalgia—Prednisone—psoriatic arthritis	0.000211	0.000732	CcSEcCtD
Dasatinib—Arthralgia—Prednisone—psoriatic arthritis	0.000211	0.000732	CcSEcCtD
Dasatinib—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000211	0.000732	CcSEcCtD
Dasatinib—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000211	0.00073	CcSEcCtD
Dasatinib—Anxiety—Prednisone—psoriatic arthritis	0.000211	0.00073	CcSEcCtD
Dasatinib—Alopecia—Methotrexate—psoriatic arthritis	0.000211	0.00073	CcSEcCtD
Dasatinib—Insomnia—Betamethasone—psoriatic arthritis	0.00021	0.000729	CcSEcCtD
Dasatinib—Insomnia—Dexamethasone—psoriatic arthritis	0.00021	0.000729	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00021	0.000727	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000209	0.000725	CcSEcCtD
Dasatinib—Discomfort—Prednisone—psoriatic arthritis	0.000209	0.000724	CcSEcCtD
Dasatinib—Mental disorder—Methotrexate—psoriatic arthritis	0.000209	0.000723	CcSEcCtD
Dasatinib—Erythema—Methotrexate—psoriatic arthritis	0.000207	0.000719	CcSEcCtD
Dasatinib—Malnutrition—Methotrexate—psoriatic arthritis	0.000207	0.000719	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000205	0.000712	CcSEcCtD
Dasatinib—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000205	0.00071	CcSEcCtD
Dasatinib—Dyspepsia—Betamethasone—psoriatic arthritis	0.000205	0.00071	CcSEcCtD
Dasatinib—Urticaria—Triamcinolone—psoriatic arthritis	0.000204	0.000706	CcSEcCtD
Dasatinib—Urticaria—Methylprednisolone—psoriatic arthritis	0.000203	0.000704	CcSEcCtD
Dasatinib—Dysgeusia—Methotrexate—psoriatic arthritis	0.000203	0.000704	CcSEcCtD
Dasatinib—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000203	0.000702	CcSEcCtD
Dasatinib—Oedema—Prednisone—psoriatic arthritis	0.000203	0.000702	CcSEcCtD
Dasatinib—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000202	0.000701	CcSEcCtD
Dasatinib—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000202	0.000701	CcSEcCtD
Dasatinib—Decreased appetite—Betamethasone—psoriatic arthritis	0.000202	0.000701	CcSEcCtD
Dasatinib—Infection—Prednisone—psoriatic arthritis	0.000201	0.000697	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000201	0.000696	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000201	0.000696	CcSEcCtD
Dasatinib—Fatigue—Betamethasone—psoriatic arthritis	0.000201	0.000695	CcSEcCtD
Dasatinib—Fatigue—Dexamethasone—psoriatic arthritis	0.000201	0.000695	CcSEcCtD
Dasatinib—Shock—Prednisone—psoriatic arthritis	0.000199	0.000691	CcSEcCtD
Dasatinib—Pain—Dexamethasone—psoriatic arthritis	0.000199	0.000689	CcSEcCtD
Dasatinib—Pain—Betamethasone—psoriatic arthritis	0.000199	0.000689	CcSEcCtD
Dasatinib—Nervous system disorder—Prednisone—psoriatic arthritis	0.000199	0.000688	CcSEcCtD
Dasatinib—Tachycardia—Prednisone—psoriatic arthritis	0.000198	0.000685	CcSEcCtD
Dasatinib—Skin disorder—Prednisone—psoriatic arthritis	0.000197	0.000682	CcSEcCtD
Dasatinib—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000196	0.000679	CcSEcCtD
Dasatinib—Vision blurred—Methotrexate—psoriatic arthritis	0.000196	0.000677	CcSEcCtD
Dasatinib—Anorexia—Prednisone—psoriatic arthritis	0.000193	0.000669	CcSEcCtD
Dasatinib—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000192	0.000667	CcSEcCtD
Dasatinib—Anaemia—Methotrexate—psoriatic arthritis	0.000192	0.000664	CcSEcCtD
Dasatinib—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000192	0.000664	CcSEcCtD
Dasatinib—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000192	0.000664	CcSEcCtD
Dasatinib—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00019	0.000659	CcSEcCtD
Dasatinib—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00019	0.000659	CcSEcCtD
Dasatinib—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000189	0.000655	CcSEcCtD
Dasatinib—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000188	0.000653	CcSEcCtD
Dasatinib—Malaise—Methotrexate—psoriatic arthritis	0.000187	0.000648	CcSEcCtD
Dasatinib—Vertigo—Methotrexate—psoriatic arthritis	0.000186	0.000646	CcSEcCtD
Dasatinib—Urticaria—Betamethasone—psoriatic arthritis	0.000185	0.00064	CcSEcCtD
Dasatinib—Urticaria—Dexamethasone—psoriatic arthritis	0.000185	0.00064	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000185	0.00064	CcSEcCtD
Dasatinib—Dizziness—Prednisolone—psoriatic arthritis	0.000184	0.000639	CcSEcCtD
Dasatinib—Asthenia—Triamcinolone—psoriatic arthritis	0.000184	0.000637	CcSEcCtD
Dasatinib—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000184	0.000637	CcSEcCtD
Dasatinib—Body temperature increased—Betamethasone—psoriatic arthritis	0.000184	0.000637	CcSEcCtD
Dasatinib—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000184	0.000637	CcSEcCtD
Dasatinib—Abdominal pain—Betamethasone—psoriatic arthritis	0.000184	0.000637	CcSEcCtD
Dasatinib—Asthenia—Methylprednisolone—psoriatic arthritis	0.000184	0.000636	CcSEcCtD
Dasatinib—Insomnia—Prednisone—psoriatic arthritis	0.000183	0.000635	CcSEcCtD
Dasatinib—Pruritus—Triamcinolone—psoriatic arthritis	0.000181	0.000629	CcSEcCtD
Dasatinib—Cough—Methotrexate—psoriatic arthritis	0.000181	0.000627	CcSEcCtD
Dasatinib—Pruritus—Methylprednisolone—psoriatic arthritis	0.000181	0.000627	CcSEcCtD
Dasatinib—Convulsion—Methotrexate—psoriatic arthritis	0.00018	0.000623	CcSEcCtD
Dasatinib—Dyspepsia—Prednisone—psoriatic arthritis	0.000178	0.000618	CcSEcCtD
Dasatinib—Chest pain—Methotrexate—psoriatic arthritis	0.000177	0.000612	CcSEcCtD
Dasatinib—Arthralgia—Methotrexate—psoriatic arthritis	0.000177	0.000612	CcSEcCtD
Dasatinib—Myalgia—Methotrexate—psoriatic arthritis	0.000177	0.000612	CcSEcCtD
Dasatinib—Decreased appetite—Prednisone—psoriatic arthritis	0.000176	0.00061	CcSEcCtD
Dasatinib—Rash—Prednisolone—psoriatic arthritis	0.000176	0.000609	CcSEcCtD
Dasatinib—Dermatitis—Prednisolone—psoriatic arthritis	0.000176	0.000609	CcSEcCtD
Dasatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000175	0.000608	CcSEcCtD
Dasatinib—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000175	0.000606	CcSEcCtD
Dasatinib—Fatigue—Prednisone—psoriatic arthritis	0.000175	0.000605	CcSEcCtD
Dasatinib—Headache—Prednisolone—psoriatic arthritis	0.000175	0.000605	CcSEcCtD
Dasatinib—Discomfort—Methotrexate—psoriatic arthritis	0.000174	0.000605	CcSEcCtD
Dasatinib—Constipation—Prednisone—psoriatic arthritis	0.000173	0.0006	CcSEcCtD
Dasatinib—Confusional state—Methotrexate—psoriatic arthritis	0.000171	0.000592	CcSEcCtD
Dasatinib—Dizziness—Triamcinolone—psoriatic arthritis	0.00017	0.000587	CcSEcCtD
Dasatinib—Dizziness—Methylprednisolone—psoriatic arthritis	0.000169	0.000586	CcSEcCtD
Dasatinib—Infection—Methotrexate—psoriatic arthritis	0.000168	0.000583	CcSEcCtD
Dasatinib—Feeling abnormal—Prednisone—psoriatic arthritis	0.000167	0.000578	CcSEcCtD
Dasatinib—Asthenia—Betamethasone—psoriatic arthritis	0.000167	0.000578	CcSEcCtD
Dasatinib—Asthenia—Dexamethasone—psoriatic arthritis	0.000167	0.000578	CcSEcCtD
Dasatinib—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000166	0.000575	CcSEcCtD
Dasatinib—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000166	0.000574	CcSEcCtD
Dasatinib—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000166	0.000574	CcSEcCtD
Dasatinib—Nausea—Prednisolone—psoriatic arthritis	0.000166	0.000574	CcSEcCtD
Dasatinib—Pruritus—Betamethasone—psoriatic arthritis	0.000165	0.00057	CcSEcCtD
Dasatinib—Pruritus—Dexamethasone—psoriatic arthritis	0.000165	0.00057	CcSEcCtD
Dasatinib—Skin disorder—Methotrexate—psoriatic arthritis	0.000164	0.00057	CcSEcCtD
Dasatinib—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000164	0.000567	CcSEcCtD
Dasatinib—Vomiting—Triamcinolone—psoriatic arthritis	0.000163	0.000565	CcSEcCtD
Dasatinib—Vomiting—Methylprednisolone—psoriatic arthritis	0.000163	0.000564	CcSEcCtD
Dasatinib—Rash—Triamcinolone—psoriatic arthritis	0.000162	0.00056	CcSEcCtD
Dasatinib—Dermatitis—Triamcinolone—psoriatic arthritis	0.000162	0.00056	CcSEcCtD
Dasatinib—Anorexia—Methotrexate—psoriatic arthritis	0.000161	0.000559	CcSEcCtD
Dasatinib—Rash—Methylprednisolone—psoriatic arthritis	0.000161	0.000559	CcSEcCtD
Dasatinib—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000161	0.000558	CcSEcCtD
Dasatinib—Urticaria—Prednisone—psoriatic arthritis	0.000161	0.000558	CcSEcCtD
Dasatinib—Headache—Triamcinolone—psoriatic arthritis	0.000161	0.000557	CcSEcCtD
Dasatinib—Headache—Methylprednisolone—psoriatic arthritis	0.00016	0.000555	CcSEcCtD
Dasatinib—Abdominal pain—Prednisone—psoriatic arthritis	0.00016	0.000555	CcSEcCtD
Dasatinib—Body temperature increased—Prednisone—psoriatic arthritis	0.00016	0.000555	CcSEcCtD
Dasatinib—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000159	0.000552	CcSEcCtD
Dasatinib—Diarrhoea—Betamethasone—psoriatic arthritis	0.000159	0.000552	CcSEcCtD
Dasatinib—Hypotension—Methotrexate—psoriatic arthritis	0.000158	0.000548	CcSEcCtD
Dasatinib—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000154	0.000535	CcSEcCtD
Dasatinib—Dizziness—Betamethasone—psoriatic arthritis	0.000154	0.000533	CcSEcCtD
Dasatinib—Dizziness—Dexamethasone—psoriatic arthritis	0.000154	0.000533	CcSEcCtD
Dasatinib—Insomnia—Methotrexate—psoriatic arthritis	0.000153	0.000531	CcSEcCtD
Dasatinib—Nausea—Triamcinolone—psoriatic arthritis	0.000152	0.000528	CcSEcCtD
Dasatinib—Nausea—Methylprednisolone—psoriatic arthritis	0.000152	0.000527	CcSEcCtD
Dasatinib—Dyspnoea—Methotrexate—psoriatic arthritis	0.000151	0.000523	CcSEcCtD
Dasatinib—Somnolence—Methotrexate—psoriatic arthritis	0.000151	0.000522	CcSEcCtD
Dasatinib—Hypersensitivity—Prednisone—psoriatic arthritis	0.000149	0.000517	CcSEcCtD
Dasatinib—Dyspepsia—Methotrexate—psoriatic arthritis	0.000149	0.000516	CcSEcCtD
Dasatinib—Vomiting—Betamethasone—psoriatic arthritis	0.000148	0.000513	CcSEcCtD
Dasatinib—Vomiting—Dexamethasone—psoriatic arthritis	0.000148	0.000513	CcSEcCtD
Dasatinib—Decreased appetite—Methotrexate—psoriatic arthritis	0.000147	0.00051	CcSEcCtD
Dasatinib—Rash—Betamethasone—psoriatic arthritis	0.000147	0.000508	CcSEcCtD
Dasatinib—Rash—Dexamethasone—psoriatic arthritis	0.000147	0.000508	CcSEcCtD
Dasatinib—Dermatitis—Dexamethasone—psoriatic arthritis	0.000147	0.000508	CcSEcCtD
Dasatinib—Dermatitis—Betamethasone—psoriatic arthritis	0.000147	0.000508	CcSEcCtD
Dasatinib—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000146	0.000507	CcSEcCtD
Dasatinib—Fatigue—Methotrexate—psoriatic arthritis	0.000146	0.000506	CcSEcCtD
Dasatinib—Headache—Dexamethasone—psoriatic arthritis	0.000146	0.000505	CcSEcCtD
Dasatinib—Headache—Betamethasone—psoriatic arthritis	0.000146	0.000505	CcSEcCtD
Dasatinib—Asthenia—Prednisone—psoriatic arthritis	0.000145	0.000504	CcSEcCtD
Dasatinib—Pain—Methotrexate—psoriatic arthritis	0.000145	0.000502	CcSEcCtD
Dasatinib—Pruritus—Prednisone—psoriatic arthritis	0.000143	0.000497	CcSEcCtD
Dasatinib—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00014	0.000483	CcSEcCtD
Dasatinib—Diarrhoea—Prednisone—psoriatic arthritis	0.000139	0.00048	CcSEcCtD
Dasatinib—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000138	0.00048	CcSEcCtD
Dasatinib—Nausea—Dexamethasone—psoriatic arthritis	0.000138	0.000479	CcSEcCtD
Dasatinib—Nausea—Betamethasone—psoriatic arthritis	0.000138	0.000479	CcSEcCtD
Dasatinib—Urticaria—Methotrexate—psoriatic arthritis	0.000135	0.000466	CcSEcCtD
Dasatinib—Dizziness—Prednisone—psoriatic arthritis	0.000134	0.000464	CcSEcCtD
Dasatinib—Abdominal pain—Methotrexate—psoriatic arthritis	0.000134	0.000464	CcSEcCtD
Dasatinib—Body temperature increased—Methotrexate—psoriatic arthritis	0.000134	0.000464	CcSEcCtD
Dasatinib—Vomiting—Prednisone—psoriatic arthritis	0.000129	0.000446	CcSEcCtD
Dasatinib—Rash—Prednisone—psoriatic arthritis	0.000128	0.000443	CcSEcCtD
Dasatinib—Dermatitis—Prednisone—psoriatic arthritis	0.000128	0.000442	CcSEcCtD
Dasatinib—Headache—Prednisone—psoriatic arthritis	0.000127	0.00044	CcSEcCtD
Dasatinib—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000125	0.000432	CcSEcCtD
Dasatinib—Asthenia—Methotrexate—psoriatic arthritis	0.000121	0.000421	CcSEcCtD
Dasatinib—Nausea—Prednisone—psoriatic arthritis	0.00012	0.000417	CcSEcCtD
Dasatinib—Pruritus—Methotrexate—psoriatic arthritis	0.00012	0.000415	CcSEcCtD
Dasatinib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriatic arthritis	0.000118	0.000496	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—REL—psoriatic arthritis	0.000118	0.000494	CbGpPWpGaD
Dasatinib—FYN—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000117	0.000491	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—REL—psoriatic arthritis	0.000116	0.000486	CbGpPWpGaD
Dasatinib—CSK—Immune System—NOD2—psoriatic arthritis	0.000116	0.000486	CbGpPWpGaD
Dasatinib—Diarrhoea—Methotrexate—psoriatic arthritis	0.000116	0.000401	CcSEcCtD
Dasatinib—RIPK2—Innate Immune System—HLA-B—psoriatic arthritis	0.000116	0.000485	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—HLA-C—psoriatic arthritis	0.000115	0.000483	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—HLA-C—psoriatic arthritis	0.000114	0.000477	CbGpPWpGaD
Dasatinib—MAP2K5—MAPK Signaling Pathway—TNF—psoriatic arthritis	0.000114	0.000476	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—HLA-C—psoriatic arthritis	0.000113	0.000473	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—HLA-C—psoriatic arthritis	0.000112	0.000471	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—NOD2—psoriatic arthritis	0.000112	0.00047	CbGpPWpGaD
Dasatinib—Dizziness—Methotrexate—psoriatic arthritis	0.000112	0.000388	CcSEcCtD
Dasatinib—JAK2—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	0.000111	0.000467	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—NOD2—psoriatic arthritis	0.000111	0.000467	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—HLA-C—psoriatic arthritis	0.000111	0.000466	CbGpPWpGaD
Dasatinib—RIPK2—Adaptive Immune System—HLA-B—psoriatic arthritis	0.000111	0.000465	CbGpPWpGaD
Dasatinib—FGR—Innate Immune System—HLA-B—psoriatic arthritis	0.000111	0.000465	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000111	0.000464	CbGpPWpGaD
Dasatinib—BLK—Immune System—HLA-C—psoriatic arthritis	0.00011	0.000459	CbGpPWpGaD
Dasatinib—FGR—Immune System—HLA-C—psoriatic arthritis	0.000109	0.000458	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—REL—psoriatic arthritis	0.000109	0.000457	CbGpPWpGaD
Dasatinib—BTK—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	0.000109	0.000456	CbGpPWpGaD
Dasatinib—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000109	0.000455	CbGpPWpGaD
Dasatinib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000109	0.000455	CbGpPWpGaD
Dasatinib—HCK—Innate Immune System—CRP—psoriatic arthritis	0.000109	0.000455	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000108	0.000454	CbGpPWpGaD
Dasatinib—Vomiting—Methotrexate—psoriatic arthritis	0.000108	0.000373	CcSEcCtD
Dasatinib—MAPK14—Innate Immune System—HLA-C—psoriatic arthritis	0.000107	0.000448	CbGpPWpGaD
Dasatinib—BLK—Adaptive Immune System—HLA-B—psoriatic arthritis	0.000107	0.000448	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—HLA-C—psoriatic arthritis	0.000107	0.000447	CbGpPWpGaD
Dasatinib—Rash—Methotrexate—psoriatic arthritis	0.000107	0.00037	CcSEcCtD
Dasatinib—Dermatitis—Methotrexate—psoriatic arthritis	0.000107	0.00037	CcSEcCtD
Dasatinib—Headache—Methotrexate—psoriatic arthritis	0.000106	0.000368	CcSEcCtD
Dasatinib—JAK2—Innate Immune System—HLA-C—psoriatic arthritis	0.000106	0.000443	CbGpPWpGaD
Dasatinib—LCK—Immune System—MEFV—psoriatic arthritis	0.000105	0.000441	CbGpPWpGaD
Dasatinib—RIPK2—Innate Immune System—CRP—psoriatic arthritis	0.000102	0.000428	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—HLA-B—psoriatic arthritis	0.000102	0.000427	CbGpPWpGaD
Dasatinib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—psoriatic arthritis	0.000101	0.000424	CbGpPWpGaD
Dasatinib—LYN—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	0.000101	0.000422	CbGpPWpGaD
Dasatinib—Nausea—Methotrexate—psoriatic arthritis	0.000101	0.000348	CcSEcCtD
Dasatinib—ERBB3—Immune System—HLA-C—psoriatic arthritis	0.000101	0.000421	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—NOD2—psoriatic arthritis	9.97e-05	0.000418	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—NOD2—psoriatic arthritis	9.95e-05	0.000417	CbGpPWpGaD
Dasatinib—FGR—Hemostasis—NOS2—psoriatic arthritis	9.94e-05	0.000416	CbGpPWpGaD
Dasatinib—FYN—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	9.93e-05	0.000416	CbGpPWpGaD
Dasatinib—FGR—Innate Immune System—CRP—psoriatic arthritis	9.81e-05	0.000411	CbGpPWpGaD
Dasatinib—ERBB3—Adaptive Immune System—HLA-B—psoriatic arthritis	9.8e-05	0.00041	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—HLA-B—psoriatic arthritis	9.76e-05	0.000409	CbGpPWpGaD
Dasatinib—BTK—Immune System—NOD2—psoriatic arthritis	9.7e-05	0.000406	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—REL—psoriatic arthritis	9.66e-05	0.000405	CbGpPWpGaD
Dasatinib—YES1—Immune System—REL—psoriatic arthritis	9.59e-05	0.000401	CbGpPWpGaD
Dasatinib—EPHB3—Developmental Biology—TNF—psoriatic arthritis	9.57e-05	0.000401	CbGpPWpGaD
Dasatinib—JAK2—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	9.44e-05	0.000395	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—NOD2—psoriatic arthritis	9.42e-05	0.000394	CbGpPWpGaD
Dasatinib—RIPK2—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	9.41e-05	0.000394	CbGpPWpGaD
Dasatinib—SRC—Immune System—MEFV—psoriatic arthritis	9.33e-05	0.000391	CbGpPWpGaD
Dasatinib—CSK—Immune System—HLA-B—psoriatic arthritis	9.33e-05	0.000391	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—HLA-C—psoriatic arthritis	9.26e-05	0.000388	CbGpPWpGaD
Dasatinib—BLK—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	9.05e-05	0.000379	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—HLA-B—psoriatic arthritis	9.03e-05	0.000378	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—CRP—psoriatic arthritis	9.02e-05	0.000378	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—HLA-B—psoriatic arthritis	8.96e-05	0.000375	CbGpPWpGaD
Dasatinib—HCK—Immune System—NOD2—psoriatic arthritis	8.9e-05	0.000373	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HLA-C—psoriatic arthritis	8.89e-05	0.000372	CbGpPWpGaD
Dasatinib—YES1—Immune System—HLA-C—psoriatic arthritis	8.82e-05	0.000369	CbGpPWpGaD
Dasatinib—YES1—Adaptive Immune System—HLA-B—psoriatic arthritis	8.6e-05	0.00036	CbGpPWpGaD
Dasatinib—KIT—Immune System—REL—psoriatic arthritis	8.56e-05	0.000359	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—REL—psoriatic arthritis	8.55e-05	0.000358	CbGpPWpGaD
Dasatinib—ABL2—Developmental Biology—TNF—psoriatic arthritis	8.53e-05	0.000357	CbGpPWpGaD
Dasatinib—EPHA3—Developmental Biology—TNF—psoriatic arthritis	8.53e-05	0.000357	CbGpPWpGaD
Dasatinib—EPHA5—Developmental Biology—TNF—psoriatic arthritis	8.53e-05	0.000357	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—NOD2—psoriatic arthritis	8.49e-05	0.000355	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—NOD2—psoriatic arthritis	8.39e-05	0.000351	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—NOD2—psoriatic arthritis	8.31e-05	0.000348	CbGpPWpGaD
Dasatinib—ERBB3—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	8.3e-05	0.000347	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—NOD2—psoriatic arthritis	8.27e-05	0.000346	CbGpPWpGaD
Dasatinib—LCK—Cytokine Signaling in Immune system—HLA-DRB1—psoriatic arthritis	8.27e-05	0.000346	CbGpPWpGaD
Dasatinib—CSK—Immune System—CRP—psoriatic arthritis	8.24e-05	0.000345	CbGpPWpGaD
Dasatinib—EPHA8—Developmental Biology—TNF—psoriatic arthritis	8.23e-05	0.000345	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—HLA-C—psoriatic arthritis	8.2e-05	0.000343	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—NOD2—psoriatic arthritis	8.18e-05	0.000342	CbGpPWpGaD
Dasatinib—EPHB4—Developmental Biology—TNF—psoriatic arthritis	8.14e-05	0.000341	CbGpPWpGaD
Dasatinib—LIMK2—Developmental Biology—TNF—psoriatic arthritis	8.14e-05	0.000341	CbGpPWpGaD
Dasatinib—EPHA4—Developmental Biology—TNF—psoriatic arthritis	8.14e-05	0.000341	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—REL—psoriatic arthritis	8.11e-05	0.000339	CbGpPWpGaD
Dasatinib—BLK—Immune System—NOD2—psoriatic arthritis	8.07e-05	0.000338	CbGpPWpGaD
Dasatinib—FGR—Immune System—NOD2—psoriatic arthritis	8.04e-05	0.000337	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—NOS2—psoriatic arthritis	8.02e-05	0.000336	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—HLA-B—psoriatic arthritis	8.02e-05	0.000336	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—HLA-B—psoriatic arthritis	8e-05	0.000335	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—CRP—psoriatic arthritis	7.98e-05	0.000334	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—CRP—psoriatic arthritis	7.92e-05	0.000332	CbGpPWpGaD
Dasatinib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—psoriatic arthritis	7.91e-05	0.000331	CbGpPWpGaD
Dasatinib—CSK—Immune System—HLA-DRB1—psoriatic arthritis	7.9e-05	0.000331	CbGpPWpGaD
Dasatinib—EPHB2—Developmental Biology—TNF—psoriatic arthritis	7.88e-05	0.00033	CbGpPWpGaD
Dasatinib—KIT—Immune System—HLA-C—psoriatic arthritis	7.88e-05	0.00033	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—NOD2—psoriatic arthritis	7.88e-05	0.00033	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HLA-C—psoriatic arthritis	7.87e-05	0.00033	CbGpPWpGaD
Dasatinib—BTK—Immune System—HLA-B—psoriatic arthritis	7.8e-05	0.000327	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—NOD2—psoriatic arthritis	7.77e-05	0.000326	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—HLA-B—psoriatic arthritis	7.68e-05	0.000322	CbGpPWpGaD
Dasatinib—EPHB6—Developmental Biology—TNF—psoriatic arthritis	7.65e-05	0.00032	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—HLA-DRB1—psoriatic arthritis	7.65e-05	0.00032	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—HLA-B—psoriatic arthritis	7.57e-05	0.000317	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HLA-C—psoriatic arthritis	7.46e-05	0.000312	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—NOD2—psoriatic arthritis	7.39e-05	0.00031	CbGpPWpGaD
Dasatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	7.34e-05	0.000307	CbGpPWpGaD
Dasatinib—PDGFRB—MAPK Signaling Pathway—TNF—psoriatic arthritis	7.33e-05	0.000307	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—REL—psoriatic arthritis	7.3e-05	0.000306	CbGpPWpGaD
Dasatinib—YES1—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	7.28e-05	0.000305	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—HLA-B—psoriatic arthritis	7.27e-05	0.000305	CbGpPWpGaD
Dasatinib—HCK—Immune System—HLA-B—psoriatic arthritis	7.16e-05	0.0003	CbGpPWpGaD
Dasatinib—LYN—Immune System—REL—psoriatic arthritis	7.15e-05	0.000299	CbGpPWpGaD
Dasatinib—ABL1—Immune System—REL—psoriatic arthritis	7.12e-05	0.000298	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—CRP—psoriatic arthritis	7.09e-05	0.000297	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—CRP—psoriatic arthritis	7.07e-05	0.000296	CbGpPWpGaD
Dasatinib—FYN—Immune System—REL—psoriatic arthritis	7.04e-05	0.000295	CbGpPWpGaD
Dasatinib—CSK—Disease—NOS2—psoriatic arthritis	6.94e-05	0.000291	CbGpPWpGaD
Dasatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	6.93e-05	0.00029	CbGpPWpGaD
Dasatinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	6.93e-05	0.00029	CbGpPWpGaD
Dasatinib—BTK—Immune System—CRP—psoriatic arthritis	6.9e-05	0.000289	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—HLA-B—psoriatic arthritis	6.82e-05	0.000286	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—NOD2—psoriatic arthritis	6.81e-05	0.000285	CbGpPWpGaD
Dasatinib—MAPK14—MAPK Signaling Pathway—TNF—psoriatic arthritis	6.8e-05	0.000285	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—HLA-DRB1—psoriatic arthritis	6.79e-05	0.000284	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—REL—psoriatic arthritis	6.78e-05	0.000284	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—HLA-B—psoriatic arthritis	6.74e-05	0.000282	CbGpPWpGaD
Dasatinib—STAT5B—Disease—NOS2—psoriatic arthritis	6.72e-05	0.000281	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HLA-C—psoriatic arthritis	6.72e-05	0.000281	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—CRP—psoriatic arthritis	6.69e-05	0.00028	CbGpPWpGaD
Dasatinib—JAK2—Immune System—REL—psoriatic arthritis	6.69e-05	0.00028	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—HLA-B—psoriatic arthritis	6.68e-05	0.00028	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—HLA-B—psoriatic arthritis	6.65e-05	0.000278	CbGpPWpGaD
Dasatinib—EPHA2—Developmental Biology—TNF—psoriatic arthritis	6.64e-05	0.000278	CbGpPWpGaD
Dasatinib—BTK—Immune System—HLA-DRB1—psoriatic arthritis	6.6e-05	0.000277	CbGpPWpGaD
Dasatinib—LYN—Immune System—HLA-C—psoriatic arthritis	6.58e-05	0.000276	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—HLA-B—psoriatic arthritis	6.58e-05	0.000275	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—HLA-B—psoriatic arthritis	6.55e-05	0.000274	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HLA-C—psoriatic arthritis	6.55e-05	0.000274	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	6.5e-05	0.000272	CbGpPWpGaD
Dasatinib—YES1—Immune System—NOD2—psoriatic arthritis	6.49e-05	0.000272	CbGpPWpGaD
Dasatinib—BLK—Immune System—HLA-B—psoriatic arthritis	6.49e-05	0.000272	CbGpPWpGaD
Dasatinib—FYN—Immune System—HLA-C—psoriatic arthritis	6.48e-05	0.000271	CbGpPWpGaD
Dasatinib—FGR—Immune System—HLA-B—psoriatic arthritis	6.46e-05	0.000271	CbGpPWpGaD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	6.44e-05	0.00027	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—HLA-B—psoriatic arthritis	6.42e-05	0.000269	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—HLA-B—psoriatic arthritis	6.33e-05	0.000265	CbGpPWpGaD
Dasatinib—HCK—Immune System—CRP—psoriatic arthritis	6.33e-05	0.000265	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—HLA-B—psoriatic arthritis	6.32e-05	0.000264	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—HLA-B—psoriatic arthritis	6.25e-05	0.000262	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HLA-C—psoriatic arthritis	6.24e-05	0.000261	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HLA-C—psoriatic arthritis	6.16e-05	0.000258	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	6.16e-05	0.000258	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	6.14e-05	0.000257	CbGpPWpGaD
Dasatinib—HCK—Immune System—HLA-DRB1—psoriatic arthritis	6.06e-05	0.000254	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—CRP—psoriatic arthritis	6.03e-05	0.000253	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—NOD2—psoriatic arthritis	6.03e-05	0.000252	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—NOS2—psoriatic arthritis	5.98e-05	0.00025	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—CRP—psoriatic arthritis	5.96e-05	0.00025	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—NOS2—psoriatic arthritis	5.95e-05	0.000249	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—HLA-B—psoriatic arthritis	5.94e-05	0.000249	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—CRP—psoriatic arthritis	5.91e-05	0.000247	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—NOS2—psoriatic arthritis	5.89e-05	0.000247	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—CRP—psoriatic arthritis	5.88e-05	0.000246	CbGpPWpGaD
Dasatinib—LCK—Immune System—REL—psoriatic arthritis	5.86e-05	0.000245	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—CRP—psoriatic arthritis	5.81e-05	0.000243	CbGpPWpGaD
Dasatinib—KIT—Immune System—NOD2—psoriatic arthritis	5.8e-05	0.000243	CbGpPWpGaD
Dasatinib—BLK—Immune System—CRP—psoriatic arthritis	5.73e-05	0.00024	CbGpPWpGaD
Dasatinib—FGR—Immune System—CRP—psoriatic arthritis	5.71e-05	0.000239	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—HLA-DRB1—psoriatic arthritis	5.71e-05	0.000239	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—NOS2—psoriatic arthritis	5.67e-05	0.000237	CbGpPWpGaD
Dasatinib—ABCB1—Allograft Rejection—TNF—psoriatic arthritis	5.63e-05	0.000236	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—CRP—psoriatic arthritis	5.6e-05	0.000234	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—NOS2—psoriatic arthritis	5.6e-05	0.000234	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	5.55e-05	0.000232	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—CRP—psoriatic arthritis	5.53e-05	0.000231	CbGpPWpGaD
Dasatinib—BLK—Immune System—HLA-DRB1—psoriatic arthritis	5.49e-05	0.00023	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—NOD2—psoriatic arthritis	5.49e-05	0.00023	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—HLA-B—psoriatic arthritis	5.48e-05	0.000229	CbGpPWpGaD
Dasatinib—FGR—Immune System—HLA-DRB1—psoriatic arthritis	5.47e-05	0.000229	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	5.43e-05	0.000227	CbGpPWpGaD
Dasatinib—LCK—Immune System—HLA-C—psoriatic arthritis	5.39e-05	0.000226	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	5.35e-05	0.000224	CbGpPWpGaD
Dasatinib—HCK—Disease—NOS2—psoriatic arthritis	5.33e-05	0.000223	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HLA-B—psoriatic arthritis	5.26e-05	0.00022	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—CRP—psoriatic arthritis	5.25e-05	0.00022	CbGpPWpGaD
Dasatinib—YES1—Immune System—HLA-B—psoriatic arthritis	5.22e-05	0.000218	CbGpPWpGaD
Dasatinib—SRC—Immune System—REL—psoriatic arthritis	5.19e-05	0.000217	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—HLA-DRB1—psoriatic arthritis	5.03e-05	0.000211	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—NOD2—psoriatic arthritis	4.94e-05	0.000207	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—NOS2—psoriatic arthritis	4.9e-05	0.000205	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—HLA-B—psoriatic arthritis	4.85e-05	0.000203	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—CRP—psoriatic arthritis	4.84e-05	0.000203	CbGpPWpGaD
Dasatinib—LYN—Immune System—NOD2—psoriatic arthritis	4.84e-05	0.000203	CbGpPWpGaD
Dasatinib—ABL1—Immune System—NOD2—psoriatic arthritis	4.82e-05	0.000202	CbGpPWpGaD
Dasatinib—SRC—Immune System—HLA-C—psoriatic arthritis	4.77e-05	0.0002	CbGpPWpGaD
Dasatinib—FYN—Immune System—NOD2—psoriatic arthritis	4.76e-05	0.000199	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	4.7e-05	0.000197	CbGpPWpGaD
Dasatinib—KIT—Immune System—HLA-B—psoriatic arthritis	4.66e-05	0.000195	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HLA-B—psoriatic arthritis	4.65e-05	0.000195	CbGpPWpGaD
Dasatinib—YES1—Immune System—CRP—psoriatic arthritis	4.61e-05	0.000193	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—NOD2—psoriatic arthritis	4.59e-05	0.000192	CbGpPWpGaD
Dasatinib—JAK2—Immune System—NOD2—psoriatic arthritis	4.53e-05	0.00019	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	4.45e-05	0.000186	CbGpPWpGaD
Dasatinib—ERBB3—Disease—NOS2—psoriatic arthritis	4.42e-05	0.000185	CbGpPWpGaD
Dasatinib—YES1—Immune System—HLA-DRB1—psoriatic arthritis	4.42e-05	0.000185	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HLA-B—psoriatic arthritis	4.41e-05	0.000185	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—NOS2—psoriatic arthritis	4.34e-05	0.000182	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—CRP—psoriatic arthritis	4.28e-05	0.000179	CbGpPWpGaD
Dasatinib—KIT—Immune System—CRP—psoriatic arthritis	4.12e-05	0.000172	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—TNF—psoriatic arthritis	4.06e-05	0.00017	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HLA-B—psoriatic arthritis	3.97e-05	0.000166	CbGpPWpGaD
Dasatinib—LCK—Immune System—NOD2—psoriatic arthritis	3.97e-05	0.000166	CbGpPWpGaD
Dasatinib—KIT—Immune System—HLA-DRB1—psoriatic arthritis	3.94e-05	0.000165	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HLA-DRB1—psoriatic arthritis	3.94e-05	0.000165	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CRP—psoriatic arthritis	3.9e-05	0.000163	CbGpPWpGaD
Dasatinib—LYN—Immune System—HLA-B—psoriatic arthritis	3.89e-05	0.000163	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HLA-B—psoriatic arthritis	3.87e-05	0.000162	CbGpPWpGaD
Dasatinib—FYN—Immune System—HLA-B—psoriatic arthritis	3.83e-05	0.00016	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HLA-DRB1—psoriatic arthritis	3.73e-05	0.000156	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HLA-B—psoriatic arthritis	3.69e-05	0.000154	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HLA-B—psoriatic arthritis	3.64e-05	0.000152	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CRP—psoriatic arthritis	3.51e-05	0.000147	CbGpPWpGaD
Dasatinib—SRC—Immune System—NOD2—psoriatic arthritis	3.51e-05	0.000147	CbGpPWpGaD
Dasatinib—KIT—Disease—NOS2—psoriatic arthritis	3.47e-05	0.000145	CbGpPWpGaD
Dasatinib—LYN—Immune System—CRP—psoriatic arthritis	3.44e-05	0.000144	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CRP—psoriatic arthritis	3.42e-05	0.000143	CbGpPWpGaD
Dasatinib—FYN—Immune System—CRP—psoriatic arthritis	3.39e-05	0.000142	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HLA-DRB1—psoriatic arthritis	3.36e-05	0.000141	CbGpPWpGaD
Dasatinib—LYN—Immune System—HLA-DRB1—psoriatic arthritis	3.29e-05	0.000138	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NOS2—psoriatic arthritis	3.28e-05	0.000137	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HLA-DRB1—psoriatic arthritis	3.28e-05	0.000137	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CRP—psoriatic arthritis	3.26e-05	0.000137	CbGpPWpGaD
Dasatinib—FYN—Immune System—HLA-DRB1—psoriatic arthritis	3.24e-05	0.000136	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CRP—psoriatic arthritis	3.22e-05	0.000135	CbGpPWpGaD
Dasatinib—LCK—Immune System—HLA-B—psoriatic arthritis	3.19e-05	0.000134	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HLA-DRB1—psoriatic arthritis	3.12e-05	0.000131	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HLA-DRB1—psoriatic arthritis	3.08e-05	0.000129	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—TNF—psoriatic arthritis	3.03e-05	0.000127	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—TNF—psoriatic arthritis	3.01e-05	0.000126	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—TNF—psoriatic arthritis	2.98e-05	0.000125	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NOS2—psoriatic arthritis	2.96e-05	0.000124	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—TNF—psoriatic arthritis	2.87e-05	0.00012	CbGpPWpGaD
Dasatinib—FYN—Disease—NOS2—psoriatic arthritis	2.85e-05	0.000119	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—TNF—psoriatic arthritis	2.83e-05	0.000119	CbGpPWpGaD
Dasatinib—SRC—Immune System—HLA-B—psoriatic arthritis	2.82e-05	0.000118	CbGpPWpGaD
Dasatinib—LCK—Immune System—CRP—psoriatic arthritis	2.82e-05	0.000118	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriatic arthritis	2.78e-05	0.000116	CbGpPWpGaD
Dasatinib—JAK2—Disease—NOS2—psoriatic arthritis	2.71e-05	0.000113	CbGpPWpGaD
Dasatinib—LCK—Immune System—HLA-DRB1—psoriatic arthritis	2.7e-05	0.000113	CbGpPWpGaD
Dasatinib—SRC—Immune System—CRP—psoriatic arthritis	2.5e-05	0.000104	CbGpPWpGaD
Dasatinib—SRC—Immune System—HLA-DRB1—psoriatic arthritis	2.39e-05	0.0001	CbGpPWpGaD
Dasatinib—LCK—Disease—NOS2—psoriatic arthritis	2.37e-05	9.94e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TNF—psoriatic arthritis	2.2e-05	9.2e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS2—psoriatic arthritis	2.1e-05	8.8e-05	CbGpPWpGaD
